Liver Flashcards
Compare HB and HCC epidemiology and RF
HB 90% <5yo
HCC 95% >15yo, 3M:F
HB: BWS, hemihypertrophy, FAP, Glycogen storage disorders, FAS, prem/LBW
HCC: glycogen storage disorders, A1-AT, hepatitis B/C, hereditary tyrosinemia, Alagille, NF-1, AT, FA
HB and HCC histologic subtypes with low/N AFP
HB small cell undifferentiated
HCC fibrolamellar
HB histologic subtypes and genetics
Epithelial (85-90%)
Fetal (10%): less aggressive
small cell undifferentiated (5%): aggressive, SMARCB1 mutation, low/N AFP
WNT
CTNNB1 activation (somatic) 70%
HCC histologic subtypes
Conventional (80%)
Fibrolamellar (20%): AYA, low/N AFP, DNAJB1-PRKACA fusion
WNT
EPHB2
TGFB1/MTOR
Transplant for HB and HCC?
HB: 10%; PRETEXT 4 or V+/P+
HCC: uncommon; multifocal confined to liver
Liver COG vs PRETEXT staging
COG postsurgical
I: GTR
II: microscopic residual disease (+ margins)
III: gross residual disease and/or nodal involvement
IV: metastatic
PRETEXT pre-surgical
Group + (# nonadjacent sections free of disease) = 4
I: 3 adjacent unaffected
II: <3 adjacent unaffected
III: 3 sections, or 2 nonadjacent sections unaffected
IV: all 4 sections
V: 3 hepatic veins/intrahepatic IVC
P: both portal veins
E: extrahepatic extension
F: multifocal
R: rupture
M: distant mets
HB risk stratification COG vs SIOP
COG
VLR: PRETEXT I-II fetal histo resected
LR: PRETEXT I-II resected
IR: PRETEXT II-IV unresectable; V/P/E; SCU histo
HR: M+, AFP <100
SIOP
SR: PRETEXT I-III
HR: V/P/E/M; SCU; AFP<100; rupture
HB Tx
COG: resection –> adj chemo (not pure fetal)
SIOP: neoadj chemo –> resection
chemo: cisplat +- doxo (SIOP HR neoadj)
AHEP1531
- LR: cisplat
- IR: cisplat, 5FU, VCR, doxo
- HR: carbo/doxo, carbo/etop, VCR/irenotecan
HB Px
VLR: OS 100%
LR: OS/EFS >90%
IR: OS/EFS >80%
HR: OS/EFS 40-60%
Worse: higher PRETEXT, PRETEXT annotation, AFP <100 or >1M, 8+yo
HCC Tx
complete resection
unresectable: neoadj
No RT
AHEP1531
- resected: cisplat/doxo (PLADO)
- unresectable/mets: cisplat/doxo/sorafenib vs addition of gemcitabine/oxaliplatin/sorafenib
HCC Px
All 5yOS 42%
localized 5yEFS <50%
distant mets 5yEFS <20%
Liver tumor - AFP prognostic?
<100 or >1M worse
HB criteria for no chemo
Pure fetal histology
PRETEXT I
complete resection
HB/HCC labs
AFP elevation
abnormal LFTs
thrombocytosis (IL-6 secretion)
rare hyperphos, Cushing